Stay updated with breaking news from Fred Junghus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preclinical data shows the robust anti-tumoral activity of BT-001, including its highly effective and safe therapeutic strategy of targeting CTLA-4STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--Regulatory News:Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherape...
STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--Regulatory News:Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery...
Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB ("BioInvent")
LUND, SE / ACCESSWIRE / October 1, 2021 / BioInvent International (STO:BINV)BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development